q2 2025 - Search News

News

Earnings Call, Q2

MiNK INKT Q2 2025 Earnings Call Transcript

Phase 2 Clinical Data -- Published results include a complete clinical response in a 49-year-old man with metastatic testicular cancer following a single dose of AGENT-797, with sustained remission beyond two years and no cytokine release syndrome or graft-versus-host disease.

Insider Monkey on MSN · 5h

Worksport Ltd. (NASDAQ:WKSP) Q2 2025 Earnings Call Transcript

Q2 2025 Earnings Call Transcript August 13, 2025 Worksport Ltd. beats earnings expectations. Reported EPS is $-0.71, expectations were $-0.76. Steven F. Rossi: [Audio Gap] Chief Financial Officer, Michael Johnston.

Seeking Alpha · 16h

Expion360 Inc. (XPON) Q2 2025 Earnings Call Transcript

Greetings, and welcome to the Expion360 Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded and will be available on the company's Investor Relations website at investors.

51m

Red Robin Q2: Surging Profits Don't Suggest A Turnaround Yet (Rating Upgrade)

Red Robin’s Q2 results came in clearly above expectations. Revenues came in at $283.7 million, down by -5.5% year-on-year but ...

7hon MSN

Foxconn sees robust AI demand continuing after Q2 profit tops forecast

Foxconn expects higher third-quarter revenue, it said on Thursday, on robust demand for artificial intelligence servers, ...

29m

CaliberCos Narrows Losses in Q2 2025

CaliberCos(NASDAQ:CWD) reported second quarter 2025 results on August 5, 2025, delivering a platform adjusted EBITDA loss of $54,000, compared to a $2.5 million loss in the second quarter of 2024 (non ...

BNY Mellon Core Plus Fund Q2 2025 Commentary

For the quarter ended June 30, 2025, BNY Mellon Core Plus Fund’s Class I shares returned 1.47%, excluding sales charges. Read ...

1hon MSN

BigBear.ai Holdings Shares Plunge. Is This a Buying Opportunity or a Red Flag?

BigBear.ai badly missed revenue expectations in Q2. The company now expects to report its lowest-ever yearly revenue as a ...

Evofem Revenue Jumps 16 Percent in Q2

GAAP revenue rose to $4.8 million in Q2 2025, up 16.0% from the prior-year period (Q2 2024, GAAP net sales) as SOLOSEC contributed to GAAP net sales growth. GAAP loss from operations improved slightly ...

Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue

The combined net Q2 2025 revenue of approximately $3.0 million for prescription and non-prescription products, including license revenue, increased approximately 35% versus net Q1 2025 revenue of ...